These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5535615)

  • 21. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 24. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of drug failure cases.
    Dingley HB
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 29. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
    Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 32. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
    Girling DJ
    Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of tuberculosis.
    Bates JH
    Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interactions of reserve antitubercular agents in combined administration].
    Korotaev GA; Kozulitsyna TM
    Probl Tuberk; 1978 Sep; (9):56-60. PubMed ID: 704600
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 37. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 38. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
    Bethlem N; Mendes W
    Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with secondary antitubercular agents].
    Ovreberg K
    Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.